Correction: Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.

Correction: Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.

[This corrects the article DOI: 10.1371/journal.pone.0221683.].

Bibliographic Details
Main Authors:	Victor J Navarro, Steven H Belle, Massimo D'Amato, Nezam Afdhal, Elizabeth M Brunt, Michael W Fried, K Rajender Reddy, Abdus S Wahed, Stephen Harrison, Silymarin in NASH and C Hepatitis (SyNCH) Study Group
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0223915

Similar Items

Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.
by: Victor J Navarro, et al.
Published: (2019-01-01)

Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
by: A.L. Chagas, et al.

Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
by: A.L. Chagas, et al.
Published: (2009-10-01)

Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis
by: Veronica Marin, et al.
Published: (2017-09-01)

Hemodynamic effects of Xiao-Chai-Hu-Tang and silymarin on cirrhotic rats
by: Chuan-Hsu Chen, et al.
Published: (2000)

The effects of concurrent treatment of silymarin and lactulose on memory changes in cirrhotic male rats
by: Mozhgan Ghobadi Pour, et al.
Published: (2020-07-01)

The Effects of Salvia miltiorrhiza and Silymarin on CBDL Induced Oxidative Damage and Mitochondrial Dysfunction in Cirrhotic Rats.
by: Chi-Jen Chen, et al.
Published: (2001)

Non-cirrhotic portal fibrosis
by: Venkatesan Mukta, et al.
Published: (2014-01-01)

Thrombosis of the Portal Venous System in Cirrhotic vs. Non-Cirrhotic Patients
by: Vania Cruz-Ramón, et al.
Published: (2018-05-01)

Fructose and Non-Alcoholic Steatohepatitis
by: Elke Roeb, et al.
Published: (2021-02-01)

Therapies for non-alcoholic steatohepatitis
by: Winston Dunn
Published: (2017-12-01)

Endocannabinoids and non-alcoholic steatohepatitis
by: Helmy Ahmed
Published: (2006-01-01)

Non-alcoholic Steatohepatitis: An Overview
by: Allison Shifflet, et al.
Published: (2009-01-01)

Xenogeneic Transplantation of Porcine Hepatocytes into the CCl Cirrhotic Rat Model
by: Andreas M. Stefan, et al.
Published: (1999-11-01)

Idiopathic non-cirrhotic portal hypertension
by: CHEN Jie
Published: (2013-07-01)

The effect of silymarin on non-alcoholic fatty liver disease of children
by: Fatemeh Famouri, et al.
Published: (2017-01-01)

Therapeutic approaches for non-alcoholic steatohepatitis
by: Luc F. Van Gaal, et al.
Published: (2021-09-01)

Signs of blood stasis in the sublingual vessels in cirrhotic and non-cirrhotic chronichepatitis B patients
by: Hong-Jen Lin, et al.
Published: (1999)

Research advances in non-cirrhotic portal hypertension
by: ZHANG Bojing, et al.
Published: (2016-02-01)

Non-Alcoholic Steatohepatitis: Clinical and Translational Research
by: Manuela G Neuman, et al.
Published: (2016-01-01)

Conophylline inhibits non-alcoholic steatohepatitis in mice.
by: Yukiomi Nakade, et al.
Published: (2017-01-01)

Role of alcohol metabolism in non-alcoholic steatohepatitis.
by: Susan S Baker, et al.
Published: (2010-03-01)

Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
by: Sven Francque, et al.
Published: (2013-10-01)

Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management
by: Federico Salomone, et al.
Published: (2015-01-01)

Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
by: Bo Zhu, et al.
Published: (2021-09-01)

Presence and Implications of Sarcopenia in Non-Alcoholic Steatohepatitis
by: Gregory Habig, et al.
Published: (2021-04-01)

Non-Alcoholic Steatohepatitis in Myotonic Dystrophy: DMPK Gene Mutation, Insulin Resistance and Development of Steatohepatitis
by: Rishi R. Bhardwaj, et al.
Published: (2010-03-01)

Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis.
by: Mei Yang, et al.
Published: (2015-01-01)

Prevalence of simple liver cysts and hemangiomas in cirrhotic and non-cirrhotic patients submitted to magnetic resonance imaging
by: Breno Victor Tomaz Galvao, et al.
Published: (2013-07-01)

Research advances in idiopathic non-cirrhotic portal hypertension
by: LIU Haibo, et al.
Published: (2017-02-01)

Non-cirrhotic portal hypertension in an ankylosing spondylitis patient
by: Sukki Park, et al.
Published: (2018-06-01)

Idiopathic non-cirrhotic portal hypertension and its causes
by: O.M. Vlasova
Published: (2018-02-01)

A Comparison of QTc Abnormalities in Cirrhotics with Non-Cirrohotic
by: M Mujtaba Ali, et al.
Published: (2020-12-01)

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
by: Singh Deepak, et al.
Published: (2010-07-01)

Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
by: Daryl Ramai, et al.
Published: (2021-02-01)

Combined alcoholic and non-alcoholic steatohepatitisKey points
by: Line Carolle Ntandja Wandji, et al.
Published: (2020-06-01)

REVIEW PAPER<br>Non-alcoholic steatohepatitis (NASH)
by: János Fehér, et al.
Published: (2005-04-01)

Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis
by: Davide Povero, et al.
Published: (2016-02-01)

Soy protein improves the progression of non-alcoholic steatohepatitis
by: Ya-Hui Tzeng, et al.
Published: (2006)

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
by: F. N. Ramalho, et al.
Published: (2017-10-01)